Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chemicon International was a prominent life science company specializing in the development and manufacture of innovative research reagents, particularly for neuroscience, stem cell research, and drug discovery. Founded in 1970 and headquartered in Temecula, California, the company became a global leader in providing high-quality primary antibodies, cell culture products, and specialized assay kits. In 2003, Chemicon was acquired by Serologicals Corporation for approximately $95 million, which significantly expanded its reach in the biotechnology market. Serologicals was subsequently acquired by Millipore Corporation in 2006, which was later integrated into Merck KGaA. Today, the Chemicon product line continues to exist as a specialized brand within the MilliporeSigma portfolio, supporting academic and pharmaceutical researchers worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chemicon International.